|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rijlaarsdam MA and Looijenga LHJ: An
oncofetal and developmental perspective on testicular germ cell
cancer. Semin Cancer Biol. 29:59–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feldman DR, Bosl GJ, Sheinfeld J and
Motzer RJ: Medical treatment of advanced testicular cancer. JAMA.
299:672–684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Einhorn LH: Clinical trials in testicular
cancer. Cancer. 71:3182–3184. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wykoff CC, Beasly NJP, Watson PH, Turner
KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell
PH, et al: Hypoxia-inducible expression of tumor-associated
carbonic anhydrases. Cancer Res. 60:7075–7083. 2000.PubMed/NCBI
|
|
6
|
Loncaster JA, Harris AL, Davidson SE,
Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford
IJ and West CM: Carbonic anhydrase IX (CA IX) expression, a
potential new intrinsic marker of hypoxia: Correlations with tumor
oxygen measurements and prognosis in locally advanced carcinoma of
the cervix. Cancer Res. 61:6394–6397. 2001.PubMed/NCBI
|
|
7
|
Vordermark D, Kaffer A, Riedl S, Katzer A
and Flentje M: Characterisation of carbonic anhydrase IX (CAIX) as
an andogenous marker of chronic hypoxia in live human tumor cells.
Int J Radiant Oncol Biol Phys. 61:1197–1207. 2005. View Article : Google Scholar
|
|
8
|
Kim SJ, Shin HJ, Jung KY, Baek SK, Shin
BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, et al: Prognostic
value of carbonic anhydrase IX and Ki-67 expression in squamous
cell carcinoma of the tongue. Jpn J Clin Oncol. 37:812–819. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harris AL: Hypoxia-a key regulatory factor
in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ratcliffe PJ: Oxygen sensing and hypoxia
signalling pathways in animals: The implications of physiology for
cancer. J Physiol. 591:2027–2042. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moon EJ, Brizel DM, Chi JT and Dewhirst
MW: The potential role of intrinsic hypoxia markers as prognostic
variables in cancer. Antioxid Redox Signal. 9:1237–1294. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pastorek J and Pastorekova S:
Hypoxia-induced carbonic anhydrase IX as a target for cancer
therapy: From biology to clinical use. Semin Cancer Biol. 31:52–64.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McCord AM, Jamal M, Shankavarum UT, Lang
FF, Camphausen K and Tofilon PJ: Physiologic oxygen concentration
enhances the stem-like properties of CD133+ human glioblastoma
cells in vitro. Mol Cancer Res. 7:489–497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lock FE, McDonald PS, Lou Y, Serrano I,
Chafe SC, Ostlund C, Aparicio S, Winum JY, Supuran CT and Dedhar S:
Targeting carbonic anhydrase IX depletes breast cancer stem cells
within the hypoxic niche. Oncogene. 32:5210–5219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ledaki I, McIntyre A, Wigfield S, Buffa F,
McGowan S, Baban D, Li JL and Harris AL: Carbonic anhydrase IX
induction defines a heterogenous cancer cell response to hypoxia
and mediates stem cell-like properties and sensitivity to HDAC
inhibition. Oncotarget. 6:19413–194127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McIntyre A, Gilbert D, Goddard N,
Looijenga L and Shipley J: Genes, chromosomes and the development
of testicular germ cell tumors of adolescents and adults. Genes
Chromosomes Cancer. 47:547–557. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sheikine Y, Gebega E, Melamed J, Lee P,
Reuter VE and Ye H: Molecular genetics of testicular germ cell
tumors. Am J Cancer Res. 2:153–167. 2012.PubMed/NCBI
|
|
18
|
Liao SY, Darcy KM, Randall LM, Tian C,
Monk BJ, Burger RA, Fruehauf JP, Peters WA, Stock RJ and Stanbridge
EJ: Prognostic relevance of carbonic anhydrase-IX in high-risk,
early-stage cervical cancer: A gynecologic oncology group study.
Gynecol Oncol. 116:452–458. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choschizick M, Oosterwijk E, Müller V,
Simon R, Moch H and Tennstedt P: Overexpression of carbonic
anhydrase IX (CAIX) is an independent unfavorable prognostic marker
in endometrioid ovarian cancer. Virchows Arch. 459:193–200. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang HJ, Kim IH, Sung CO, Shim JH and Yu
E: Expression of carbonic anhydrase 9 is a novel prognostic marker
in resectable hepatocellular carcinoma. Virchows Arch. 466:403–413.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steward GD, O'Mahony FC, Laird A, Rashid
S, Martin SA, Eory L, Lubbock AL, Nanda J, O'Donnell M, Mackay A,
et al: Carbonic anhydrase 9 expression increases with vascular
endothelial growth factor-targeted therapy and is predictive of
outcome in metastatic clear cell renal cancer. Eur Urol.
66:956–963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao Z, Liao G, Li Y, Zhou S, Zou H and
Fernando S: Prognostic value of carbonic anhydrase IX
immunohistochemical expression in renal cell carcinoma: A
metaanalysis of the literature. PLoS One. 9:e1140962014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ilie M, Mazure NM, Hofman V, Ammadi RE,
Ortholan C, Bonnetaud C, Havet K, Venissac N, Mograbi B, Mouroux J,
et al: High levels of carbonic anhydrase IX in tumour tissue and
plasma are biomarkers of poor prognostic in patients with non-small
cell lung cancer. Br J Cancer. 102:1627–1635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kock L, Mahner S, Choschzick M, Eulenburg
C, Milde-Langosch K, Schwarz J, Jaenicke F, Müller V and Woelber L:
Serum carbonic anhydrase IX and its prognostic relevance in vulvar
cancer. Int J Gynecol Cancer. 21:141–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Müller V, Riethdorf S, Rack B, Janni W,
Fasching PA, Solomayer E, Aktas B, Kasimir-Bauer S, Zeitz J, Pantel
K, et al: Prospective evaluation of serum tissue inhibitor of
metalloproteinase 1 and carbonic anhydrase IX in correlation to
circulating tumor cells in patients with metastatic breast cancer.
Breast Cancer Res. 13:R712011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Woelber L, Kress K, Kersten JF, Choschzick
M, Kilic E, Herwig U, Lindner C, Schwarz J, Jaenicke F, Mahner S,
et al: Carbonic anhydrase IX in tumor tissue and sera of patients
with primary cervical cancer. BMC Cancer. 11:122011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang JS, Chen MK, Yang SF, Chang YC, Su
SC, Chiou HL, Chien MH and Lin CW: Increased expression of carbonic
anhydrase IX in oral submucous fibrosis and oral squamous cell
carcinoma. Clin Chem Lab Med. 52:1367–1377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zat'ovicová M, Tarábková K, Svastová E,
Gibadulinová A, Mucha V, Jakubícková L, Biesová Z, Rafajová M, Gut
M Ortova, Parkkila S, et al: Monoclonal antibodies generated in
carbonic anhydrase IX-deficient mice recognize different domains of
tumour-associated hypoxia-induced carbonic anhydrase IX. J Immunol
Methods. 282:117–134. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mostofi FK and Sesterhenn IA: Tumours of
the testis and paratesticular tissuePathology and Genetics of
Tumours of the Urinary System and Male Genital Organs (IARC WHO
Classification of Tumours). Eble JN, Sauter G, Epstein JI and
Sesterhenn IA: IARC Press; Lyon: pp. 216–278. 2004
|
|
30
|
Pastoreková S, Závadová Z, Kostál M,
Babusíková O and Závada J: A novel quasi-viral agent, MaTu, is a
two-component system. Virology. 187:620–626. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takacova M, Bullova P, Simko V, Skvarkova
L, Poturnajova M, Feketeova L, Babal P, Kivela AJ, Kuopio T,
Kopacek J, et al: Expression pattern of carbonic anhydrase IX in
Medullary thyroid carcinoma supports a role for RET-mediated
activation of the HIF pathway. Am J Pathol. 184:953–965. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
deWit R, Roberts JT, Wilkinson PM, de
Mulder PH, Mead GM, Fossa SD, Cook P, de Prijck L, Stenning S and
Collette L: Equivalence of three or four cycles of bleomycin,
etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule
in good-prognosis germ cell cancer: A randomized study of the
European Organization for Research and Treatment of Cancer
Genitourinary Tract Cancer Cooperative Group and the Medical
Research Council. J Clin Oncol. 19:1629–1640. 2001.PubMed/NCBI
|
|
33
|
Bokenmeyer C, Kollmannsberger C, Stenning
S, Hartmann JT, Horwich A, Clemm C, Gerl A, Meisner C, Ruckerl P,
Schmoll HJ, et al: Metastatic seminoma treated with either single
agent carboplatin or cisplatin-based combination chemotherapy: A
pooled analysis of two randomised trials. Br J Cancer. 91:683–687.
2004.PubMed/NCBI
|
|
34
|
Einhorn LH: Treatment of testicular
cancer: A new and improved model. J Clin Oncol. 8:1777–1781.
1990.PubMed/NCBI
|
|
35
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:573–584.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rofstad EK: Microenviroment-induced cancer
metastasis. Int J Radiat Biol. 76:589–605. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ljungkvist AS, Bussink J, Kaanders JH and
van der Kogel AJ: Dynamics of tumor hypoxia measured with
bioreductive hypoxic cell markers. Radiat Res. 167:127–145. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ostheimer C, Bache M, Güttler A, Kotzsch M
and Vordermark D: A pilot study on potential plasma hypoxia markers
in the radiotherapy of non-small cell lung cancer. Osteopontin,
carbonic anhydrase IX and vascular endothelial growth factor.
Strahlenther Onkol. 190:276–282. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hyrsl L, Zavada J, Zavadova Z, Kawaciuk I,
Vesely S and Skapa P: Soluble form of carbonic anhydrase IX (CAIX)
in transitional cell carcinoma of urinary tract. Neoplasma.
56:298–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vranic S, Hes O, Grossmann P and Gatalica
Z: Low frequency of HIF-1α overexpression in germ cell tumors of
the testis. Appl Immunohistochem Mol Morphol. 21:165–169.
2013.PubMed/NCBI
|
|
41
|
Zhou GX, Ireland J, Rayman P, Finke J and
Zhou M: Quantification of carbonic anhydrase IX expression in serum
and tissue of renal cell carcinoma patients using enzyme-linked
immunosorbent assy: Prognostic and diagnostic potentials. Urology.
75:257–261. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Suzuki J Jr, Therrien J, Filion F,
Lefebvre R, Goff AK and Smith LC: In vitro culture and somatic cell
nuclear transfer affect imprinting of SNRPN gene in pre- and
post-implantation stages of development in cattle. BMC Dev Biol.
9:92009. View Article : Google Scholar : PubMed/NCBI
|
